Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis

Documenti analoghi

• Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study
  di: Sizheng Steven Zhao, et al.
  Pubblicazione: (2024)
• Incidence and Genetic Risk of Juvenile Idiopathic Arthritis in Norway by Latitude
  di: Sigrid V. Hestetun, et al.
  Pubblicazione: (2024)
• Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First‐Line Therapy
  di: Ilaria Maccora, et al.
  Pubblicazione: (2026)
• Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis
  di: Chuan Fu Yap, et al.
  Pubblicazione: (2025)
• Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis
  di: Viola Pitkänen, et al.
  Pubblicazione: (2025)